Melanie Greenland

I completed my BSc in Mathematics at the University of Birmingham in 2013 and my MSc in Biometry at the University of Reading in 2014. For my dissertation I conducted research into methods for handling missing data in cohort studies focusing on multiple imputation methods. 

I worked at a contract research organisation as a Graduate Biostatistician in Phase I-III clinical trials for several therapeutic areas. I then worked as a Medical Statistician at the National Perinatal Epidemiology Unit Clinical Trials Unit (NPEU CTU) at the University of Oxford focusing on women's reproductive health, obstetrics and neonatal research. I continue to collaborate with NPEU CTU and am currently performing the long-term follow-up analysis for the Phoenix trial.

In 2016 I relocated to Australia and became a Research Associate in the Cardiovascular Research Group at the University of Western Australia (UWA). I published a SAS program for calculating adherence to medication polypharmacy in collaboration with researchers at UWA and the University of Basel. I presented at the Australasian Epidemiology Association conference in 2018 on cardioprotective medication adherence using advanced statistical techniques and I am the first author on the corresponding paper. Additionally, I co-supervised and provided statistical support to honours, masters and medical students.

On returning to Oxford in 2019, I worked as Medical Statistician in the Clinical Trial Service Unit and Epidemiological Studies Unit focusing on the aetiology of cardiovascular diseases and diseases of old age using the prospective UK Biobank cohort study data linked to electronic health data.

I joined the Oxford Vaccine Group as a Medical Statistician in late 2020 and am involved in coronavirus, respiratory syncytial virus and typhoid fever vaccination trials.